Located on the hillside of northern part of Osaka, the Northern Osaka Biomedical Cluster illustrates a highest potential in life science.
The Kansai region (Osaka, Kobe and Kyoto metropolitan areas) is the heart of Japan’s biotech industry and is home to top biomedical clusters that are open to the international community.
These clusters feature many pharmaceutical companies, medical institutions, bio ventures, and research institutions.
The Kansai region offers an excellent environment perfectly suited for partnering in areas ranging from exploratory research in drug discovery to production and sales of pharmaceuticals.
The EU-Japan Centre currently produces 5 newsletters :
Joint venture established in 1987 by the European Commission (DG GROW) and the Japanese Government (METI) for promoting all forms of industrial, trade and investment cooperation between the EU and Japan.
The EU-Japan Centre’s activities are subject to the allocation of a Grant Agreement by the European Commission for 2024-2026
